Miaoli County, Taiwan

Chih-Hsiang Leng

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Zhunan Town, TW (2011 - 2014)
  • Taipei, CN (2019)
  • Taipei, TW (2019)
  • Miaoli County, TW (2010 - 2021)
  • Zhunan, TW (2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Chih-Hsiang Leng: Pioneering Innovations in Immunology and Cancer Research

Introduction:

Chih-Hsiang Leng, an esteemed inventor and researcher hailing from Miaoli County, Taiwan, has made significant contributions to the fields of immunology and cancer research. With a strong focus on enhancing immune responses and combating cancer, Leng has garnered recognition for his groundbreaking work. Let us delve deeper into his illustrious career and explore some of his most recent patents.

Latest Patents:

Leng's latest patents demonstrate his expertise and ingenuity in the development of novel pharmaceutical compositions and treatment methods. Two notable patents include:

1. Compositions and Methods for Enhancement of Immune Responses: This patent introduces a pharmaceutical composition comprising an antigen fusion protein that includes an antigen and an antagonist of an Fc gamma receptor. By conjugating the antigen with the antagonist, Leng's invention enhances the immunogenicity of the antigen, leading to improved immune responses. This breakthrough has significant implications in developing potent vaccines that can effectively target vaccine antigens to antigen-presenting cells, promoting a robust immune response.

2. Immunogenic Peptide Containing a B Cell Epitope of Tumor-Associated Antigen L6: In this patent, Leng introduces an immunogenic peptide containing the sequence CLDSLGQWN. This peptide holds promise as a potential treatment for cancer, showcasing Leng's commitment to advancing cancer research and therapeutics.

Career Highlights:

Throughout his career, Chih-Hsiang Leng has achieved numerous milestones, revolutionizing existing technologies and introducing innovative solutions. His contributions to immunology and cancer research have opened new possibilities in various industries. Some of his career highlights include:

1. Extensive Experience with Prestigious Institutions: Leng has worked with prominent research organizations such as the National Health Research Institutes and Academia Sinica, leveraging his expertise and collaborating with esteemed scientists to advance scientific knowledge.

2. Significant Patent Portfolio: With a remarkable total of 16 patents to his name, Leng's inventions have made a tangible impact in the field of healthcare, bringing forth improved treatments and therapies.

Collaborations:

Collaboration has been a key aspect of Chih-Hsiang Leng's career, allowing him to combine his expertise with that of other accomplished individuals. Noteworthy collaborations include:

1. Pele Choi-Sing Chong: Leng has worked alongside Pele Choi-Sing Chong, a respected researcher in the field of immunology. Their collaboration has likely resulted in fruitful synergies and advancements in the realm of immune response enhancement.

2. Hsin-Wei Chen: Leng has also collaborated with Hsin-Wei Chen, contributing to the joint efforts in exploring cancer treatment strategies. Through their combined expertise, they have made noteworthy strides towards developing novel therapies for combating cancer.

Conclusion:

Chih-Hsiang Leng's remarkable career in immunology and cancer research is characterized by groundbreaking inventions and significant contributions. His innovative approach to enhancing immune responses and developing new cancer treatments has the potential to transform healthcare and improve patient outcomes. With a strong patent portfolio and fruitful collaborations, Leng continues to push the boundaries of scientific discovery, shaping the future of immunotherapy and cancer therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…